UKCPA and BOPA joint response to pharmacist apprenticeship consultation

UKCPA and BOPA joint response to pharmacist apprenticeship consultation

The United Kingdom Clinical Pharmacy Association (UKCPA) and the British Oncology Pharmacy Association (BOPA) understand that this is a subject of interest to our members.

This proposal has come with minimal details and a short time-frame for us to consult with and respond on behalf of our members. We understand that there was no formal approach to widely engage with the profession. Only recently, when the General Pharmaceutical Council was consulting on initial education and training standards for pharmacists, this proposal was not alluded to in any of the plans. It is also unclear how this approach to education would align with the NHS 10-year plan and other national directions.

As we aim to work with our members to contribute to future consultations on this subject, we encourage a more detailed proposal and a longer engagement period.
 
Further information
The proposal can be found on the Institute for Apprenticeships and Technical Education (IATE) website. The closing date is 14 April 2019.
 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article